Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market™ technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane™, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane™ sweetener. We show 24 historical shares outstanding datapoints in our AMRS shares outstanding history coverage, used to compute AMRS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AMRS market cap history over the course of time is important for investors
interested in comparing AMRS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AMRS versus a peer is one thing; comparing
AMRS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AMRS can fluctuate over the course of history.
With this page we aim to empower investors researching AMRS by allowing them to research the AMRS market cap history. |
Free AMRS Email Alerts:
Video: The Importance of Market Cap
